Bionano Genomics
The San Diego-based genomic analysis company announced five strategic pillars to help establish optical genome mapping (OGM) in the clinic.
Genomic Study Reveals Recurrent Inversion Variants, Instability Effects
Genomic data for 41 individuals representing 82 haplotypes helped unearth recurrent inversion polymorphisms, including variants overlapping with disease-related sites.
Bionano Genomics Q1 Revenues Rise 78 Percent
The San Diego-based optical genome mapping company reported Q1 total revenues of $5.7 million, a 78 percent increase compared to $3.2 million a year ago.
Bionano is bolstering its presence in China with the desire to eventually seek NMPA approval for its Saphyr optical genome mapping platform.
Mar 1, 2022
Bionano Genomics Q4 Revenues up 58 Percent
Nov 4, 2021
Bionano Genomics More Than Doubles Q3 Revenues
Aug 4, 2021
Bionano Genomics Q2 Revenues More Than Triple
May 13, 2021
Bionano Genomics Q1 Revenues Almost Triple
Mar 24, 2021
Mar 23, 2021
Bionano Genomics Q4 Revenues Grow 43 Percent
Nov 12, 2020